48
Office of Diversion Control, ODE 1 Christine A. Sannerud, Chief Drug and Chemical Evaluation Section (ODE) U.S. Drug Enforcement Administration (202) 307-7183

Christine A. Sannerud, Chief Drug and Chemical Evaluation ... · Office of Diversion Control, ODE 1 Christine A. Sannerud, Chief Drug and Chemical Evaluation Section (ODE) U.S. Drug

  • Upload
    vantu

  • View
    219

  • Download
    0

Embed Size (px)

Citation preview

Office of Diversion Control, ODE 1

Christine A. Sannerud, Chief

Drug and Chemical Evaluation Section (ODE)U.S. Drug Enforcement Administration

(202) 307-7183

Office of Diversion Control, ODE 2

Drug and Chemical Evaluation Section (ODE) Chemical Role includes:

• Determination of chemicals used in the manufacture of controlled substances.

• Use of existing regulatory mechanisms to control compounds used in this manufacture.

Office of Diversion Control, ODE 3

Current Activities

• Iodine Regulations (NPRM)• Sodium Permanganate• Elimination of Ephedrine/Pseudoephedrine

Chemical Mixture Exemptions• Control of Precursors to Fentanyl• Positional Isomers Definition

Office of Diversion Control, ODE 4

Methamphetamine Production

Office of Diversion Control, ODE 5

Iodine Control

• Iodine used as reagent in Methamphetamine production

• Number one U.S. clandestinely produced drug

Office of Diversion Control, ODE 610/2/2006

WASH

OREGON

CA

NEVADA

IDAHO

MONTANA N DAKOTA

WYOMINGS DAKOTA

MN

IOWA

UTAH

ARIZONANEWMEXICO

COLORADOKANSAS

OKLAMISSOURI

ARK

LA

MS

TN

AL GA

FL

SC

NC

KY

WV

VA

ILL IN OHIO PA

NY

VTME

NHMA

RICT

NJDE

MDDC

TEXAS

WI

MI

NEBRASKA

1995 - 327

23 29

16108

13

10

16 37

19

10

11

1

11

1

1996 - 879WASH

OREGON

CA

NEVADA

IDAHO

MONTANA N DAKOTA

WYOMINGS DAKOTA

MN

IOWA

UTAH

ARIZONANEW

MEXICO

COLORADOKANSAS

OKLAMISSOURI

ARK

LA

MS

TN

AL GA

FL

SC

NC

KY

WV

VA

ILL IN OHIO PA

NY

VTME

NHMA

RICT

NJDEMD

DC

TEXAS

WI

MI

NEBRASKA

37 63

83155

43

7425

17

4

10

3

2

14

7 71

8

12

2

12

2

2355

3

MethamphetamineClandestine Laboratory Seizures

With DEA participation

U.S. Department of JusticeDrug Enforcement AdministrationOffice of Diversion ControlChemical Investigations Section

1993 - 218WASH

OREGON

CA

NEVADA

IDAHO

MONTANA N DAKOTA

WYOMINGS DAKOTA

MN

IOWA

UTAH

ARIZONA NEWMEXICO

COLORADO KANSAS

OKLA

MISSOURI

ARK

LA

MS

TN

AL GA

FL

SC

NC

KY

WV VA

ILL

IN OHIOPA

NY

VTME

NHMA

RICT

NJDEMD

DC

TEXAS

WI

MI

NEBRASKA

110

10

12

11

10

1994 - 263WASH

OREGON

CA

NEVADA

IDAHO

MONTANA N DAKOTA

WYOMINGS DAKOTA

MN

IOWA

UTAH

ARIZONANEW

MEXICO

COLORADOKANSAS

OKLA

MISSOURI

ARK

LAMS

TN

AL GA

FL

SC

NC

KY

WV VA

ILL IN OHIO PA

NY

VTME

NHMA

RICT

NJDEMD

DC

TEXAS

WI

MI

NEBRASKA

14 25

15115

14

21

12

11

10>5 - 92 - 41

DE--1DC--1421

191

10

19

139

115 26

20

25

46

107

14

22

12

14

23169

5 3

3 4

4

4

238 7

1

2

1

12

1

11

1

1997 - 1431

366

164

30

27

226

111 51

29

38

29

106

41

19

18

50

43149

13 5

1 5

1

3

1

12 5

3

7

133

41

1

1998 -1623

8

5

18

2

4

5

DE--1MA--2ME--1NH--1NJ--1

Office of Diversion Control, ODE 7

DEA and State and Local Law Enforcement Methamphetamine Seizures(Includes Labs, dump sites, glassware and equipment seizures)

Calendar Years 1999 – 2005 (Reported through June 2006)

74389092

13537

1621217356 17170

12139

02000400060008000

100001200014000160001800020000

1999 2000 2001 2002 2003 2004 2005

Office of Diversion Control, ODE 8

• P2P + Methylamine d,l-methamphetamine

• Ephedrine + Hydriodic Acid + Red-P d-methamphetamine

Methamphetamine Production

Office of Diversion Control, ODE 9

Methamphetamine Production

• Ephedrine + Hydriodic Acid + Red-P d-methamphetamine•

• Pseudoephedrine + Iodine + Red-P d-methamphetamine• or Ephedrine Crystals

•• Pseudoephedrine + Iodine + Red-P d-methamphetamine• or Ephedrine Tincture*

• * Hydrogen Peroxide used to precipitate out crystals

Office of Diversion Control, ODE 10

Office of Diversion Control, ODE 11

“Mexican Crime Group Methamphetamine‘SUPER LAB’ Seizure in California.”

Office of Diversion Control, ODE 12

“Two Large Capacity Methamphetamine Clan Labs.”

Office of Diversion Control, ODE 13

Existing Iodine Controls

• List II Chemical• Threshold 0.4 kilograms• Only domestic transactions regulated• Import/Export transactions exempted• Iodine tinctures (considered chemical

mixtures) are exempt

Office of Diversion Control, ODE 14

Iodine Problem

• Widely used in clandestine laboratories• Since tinctures are exempt, lab operators

have discovered they can acquire unregulated 7% tincture, add hydrogen peroxide and precipitate out iodine crystals for clan lab use

• Scope of diversion is an international problem

Office of Diversion Control, ODE 15

Proposed Changes to Iodine Regulations

• NPRM Published August 11, 2006 with 60-day comment period

• Move from List II to List I– Impose registration requirement

• Add Import/Export Controls• Remove threshold so that all transactions regulated

regardless of size• Control chemical mixtures at concentration level which

will regulate 7% iodine tincture– Used primarily in livestock/horse industry– No household use

Office of Diversion Control, ODE 16

Iodine Control

• Will not adversely impact any of the iodine products sold in retail drug store setting

• Will exempt iodine-povidone complexes (all concentrations)

• Will not regulate iodine 2% tincture• Will not control any of the iodide compounds sold

via prescription or radiolabeled for diagnostic purposes.

• Currently reviewing comments and considering further exemptions where appropriate

Office of Diversion Control, ODE 17

Sodium Permanganate

Office of Diversion Control, ODE 18

Sodium Permanganate

• Direct Substitute for Potassium Permanganate in cocaine processing

• NPRM to control as a List II chemical published March 1, 2005

• Final Rule published October 17, 2006

Office of Diversion Control, ODE 19

Cocaine Production

Office of Diversion Control, ODE 20

TYPES OF CHEMICALS HISTORICALLY USED IN THE PRODUCTION OF COCAINE

SOLVENTS -

ACIDS -

BASES -

OXIDANTS -

Methyl Ethyl Ketone (MEK), Methyl isobutyl Ketone (MIBK), Acetone, Ethyl ether, Toluene, Kerosene

Sulfuric Acid Hydrochloric Acid

Calcium, Sodium or Potassium Carbonate, Calcium Oxide Ammonia Water

Potassium Permanganate

Office of Diversion Control, ODE 21

Office of Diversion Control, ODE 22

PRODUCTION OF ILLICIT COCAINE FOUR STEPS

COLLECTION OF COCA LEAVES

PRODUCTION OF COCA PASTE BY SOLVENT PROCESS OR

ACID PROCESS

PRODUCTION OF COCAINE BASE

PRODUCTION OF COCAINE HYDROCHLORIDE

Office of Diversion Control, ODE 23

Production of Coca Base

COCA PASTE

ADD DILUTE SULFURIC ACID; ADD POTASSIUM PERMANGANATE;

MIX AND FILTERSolids SOLUTION OF ACID

WITH COCAINE

ADD AMMONIA WATER; MIX; FILTER

LiquidCOCAINE BASE

Office of Diversion Control, ODE 24

Office of Diversion Control, ODE 25

Sodium Permanganate

• Direct Substitute for Potassium Permanganate• Potassium permanganate one of the most

important chemicals for cocaine production• U.S. producers changing production toward

increase production of Sodium Permanganate• Sodium Permanganate available as a 40% solution

has advantage of being miscible with water in all proportions (Potassium Permanganate has only 6.38% solubility in water)

Office of Diversion Control, ODE 26

Proposed Controls for Sodium Permanganate

• Since directly substitutable for Potassium Permanganate

• Propose Same level of Control• List II – No Registration• Thresholds: 55 kgs domestic, 500 kgs

import/export• Chemical Mixtures <= 15 percent exempt

Office of Diversion Control, ODE 27

Ephedrine/ PseudoephedrineExemptions

Office of Diversion Control, ODE 28

Ephedrine/ Pseudoephedrine Exemptions

This Interim Rule announces the removal of the CSA exemptions for chemical mixtures containing ephedrine and/or pseudoephedrine.

• In a Final Rulemaking [68 FR 23195] published on May 1, 2003, DEA initially created an exemption from CSA chemical regulations for all chemical mixtures containing five percent or less total ephedrine/pseudoephedrine.

• Additionally, that rulemaking created an exemption for chemical mixtures consisting of unaltered harvested plant material containing ephedrine alkaloids (e.g. ephedra).

• This Interim Rule, however, removes these two exemptions. Therefore, these materials shall now be subject to all CSA provisions.

Office of Diversion Control, ODE 29

• The Combat Methamphetamine Epidemic Act of 2005 (CMEA) added additional controls on ephedrine and pseudoephedrine and mandated that DEA limit the domestic production and importation of materials containing ephedrine and pseudoephedrine to quantities necessary for medical, scientific and other legitimate purposes.

• DEA has growing concerns regarding ephedra and dietary supplements containing ephedra, and their use as the source of the precursor material for use in the illicit production of methamphetamine.

• While the FDA has taken action to eliminate ephedra dietary supplements from the U.S. market, DEA has seen increases in number of import requests for ephedra, leading to a concern thatthese products are being diverted for use in illicit manufactureof methamphetamine.

Office of Diversion Control, ODE 30

• Given these concerns, and Congressional direction to limit the importation of materials containing ephedrine/ pseudoephedrine, DEA is eliminating the exemptions for this material.

Office of Diversion Control, ODE 31

Clandestine Fentanyl

Office of Diversion Control, ODE 32

Pharmacology

• Synthetic opioid• Schedule II narcotic• Low therapeutic index

Euphoria vs respiratory depression

• Effects are similar to morphine and heroin, but with two principle differences:

1) Duration of action (rapid onset, shorter acting)

2) Potency (much greater potency)50 -100x more potent analgesic than Morphine30 - 50 x more potent analgesic than Heroin

Potency depends on route of administration and the effect being measured

Office of Diversion Control, ODE 33

History of Fentanyl Abuse• 1970’s to present – Abuse of injectables

Medical professionals (doctors/nurses/pharmacists) often in a hospital setting

• 1990’s to present– Abuse of transdermal patch & Troche

• 2000’s – Clan labs making fentanyl6 Fentanyl clan labs since 20005 of which are known or suspect to have used Siegfried MethodDEA preparing regulations to control precursor chemicals499 Confirmed Death + 288 Suspected deaths in U.S.

Office of Diversion Control, ODE 34

Illicitly Manufactured Fentanyl-Related Deaths by Location Since 3/4/2005

(DEA Compiled: 10/12/06)

207606Total Deaths =>

13Other areas

1427St. Louis, Missouri

45New York State

57Rest of PA

14215Philadelphia, PA/Camden, NJ/Wilmington, DE

62150Detroit, Michigan

2214Chicago, Illinois

SuspectedDeaths

ConfirmedDeaths

Location(City/area and surrounding counties)

Office of Diversion Control, ODE 35

Illicitly Manufactured Fentanyl-Related Deaths/Week in U.S.From March 4, 2005 – August 5, 2006(Total DEA Confirmed Deaths Graphed: 606)

0

5

10

15

20

25

30

35

404/

10/0

5

5/8/

05

6/5/

05

7/3/

05

7/31

/05

8/28

/05

9/25

/05

10/2

3/05

11/2

0/05

12/1

8/05

1/15

/06

2/12

/06

3/12

/06

4/9/

06

5/7/

06

6/4/

06

7/2/

06

7/30

/06

Week (Sun. to Sat.) Compiled 10/12/2006

Num

ber o

f Dea

ths

Office of Diversion Control, ODE 36

Clandestine Lab in Toluca, Mexico

Fentanyl Production

Drug and Chemical Evaluation, Drug Enforcement Administration, Department of Justice

Sunday, May 21, 2006 PGR/SIEDO and AFI

Office of Diversion Control, ODE 37

Siegfried MethodImine

Office of Diversion Control, ODE 38

Control of Precursors

• DEA is moving to control precursors:– NPP (N-phenethyl-4-piperidone) as a listed

chemical in List I– ANPP (4-anilino-N-phenethyl-4-piperidine) as

an immediate precursor in Schedule II

Office of Diversion Control, ODE 39

Legitimate Uses Of NPP• Legitimate uses of NPP:

Pharmaceutical Industry Pharmaceutical R&D to synthesis experimental compoundsAnalytical Reference Standards

• Drugs prepared from NPP:FentanylCarfentanylCinitapride – gastrointestinal motility agentFenspiride – nonsteroidal anti-flammatory agent

Specialty ChemicalLow volumeOnly 6 domestic chemical suppliers of NPPOnly 24 domestic purchases since January 1, 2004

Office of Diversion Control, ODE 40

Fentanyl Synthesis: Siegfried Method

NPP ANPP Fentanyl

Office of Diversion Control, ODE 41

Siegfried Method: Making ANPP

NPP

Add Aniline/Molecular Sieves

Stir 24 hrs at room temp

ImineNaBH4

Clean up stageAdd H2O & HCl

Stir for 3 hrs at room temp

Aqueous Phase

NaOH

ExtractionDry

IsolateANPP

crystals

Office of Diversion Control, ODE 42

Siegfried Method: Making Fentanyl

ANPP

Add propionyl chloride slowly

Stir 1hr at room temp

FentanylExtract & Dry

Office of Diversion Control, ODE 43

LA Area Fentanyl / MDA LabNovember 2005, law enforcement seized a lab in the LA area suspected to be Fentanyl lab.

Chemists analyzed the samples submitted and confirmed fentanyl and MDA present.

A 5 kilogram bag of “NPP” (1-phenethyl-4 piperidone) precursor was seized.

Office of Diversion Control, ODE 44

Definition of Positional Isomers

• This Rulemaking establishes a specific, technical definition for the term “positional isomer” as it relates to Schedule I hallucinogens.

Office of Diversion Control, ODE 45

Background: Positional Isomers• The CSA (21 U.S.C. 802(14) and 21 U.S.C. 812(c)(I)(c))

specify which hallucinogenic compounds are considered Schedule I Controlled Substances. The CSA states that all salts, isomers and salts of isomers of these compounds are also Schedule I Controlled Substances.

• Under 21 CFR 1308.11(d), the CSA states that the term isomers shall include “optical, positional and geometric isomers”.

• Optical and geometric isomerism easily determined.

• The definition will include precise language that will allow for an unambiguous determination of which isomers of Schedule I hallucinogenic substances are considered to be “positional”, and therefore subject to Schedule I control.

Office of Diversion Control, ODE 46

• The addition of a definition for the term “positional isomer” will assist legitimate research and industry in determining the control status of materials that are isomers of Schedule I hallucinogens.

• While DEA will remain the authority on ultimately determining the control status of a given material, providing a specific definition for “positional isomer” will ensure consistent criteria are utilized in making these determinations.

• The addition of a definition for the term “positional isomer” will not result in the control of additional substances or have a negative impact on legitimate researchers or industry working with isomers of Schedule I hallucinogenic substances.

Office of Diversion Control, ODE 47

Status: Positional Isomers

• A Notice of Proposed Rulemaking (NPRM) was Published in Federal Register on May 25, 2006

• A final rule is being circulated for signature.

Office of Diversion Control, ODE 48

Christine A. Sannerud, Chief

Drug and Chemical Evaluation Section (ODE)U.S. Drug Enforcement Administration

(202) 307-7183